Cite
HARVARD Citation
Cecchi, I. et al. (n.d.). FRI0048 The ANTI-CD20 antibody rituximab reduces the inflammatory and prothrombotic profile of leukocytes from rheumatoid arthritis patients and modulates the activity of endothelial cells. Annals of the rheumatic diseases. p. 497. [Online].